Development of a prognostic model for overall survival in multiple myeloma using the Connect(®) MM Patient Registry

Median overall survival (OS) has improved for patients with newly diagnosed multiple myeloma (NDMM), but prognosis varies depending on baseline patient characteristics. Current models use data from selected clinical trial populations, which prevent application to patients in an unselected community...

Descripción completa

Detalles Bibliográficos
Autores principales: Terebelo, Howard R., Abonour, Rafat, Gasparetto, Cristina J., Toomey, Kathleen, Durie, Brian G. M., Hardin, James W., Jagannath, Sundar, Wagner, Lynne, Narang, Mohit, Flick, E. Dawn, Srinivasan, Shankar, Yue, Lihua, Kitali, Amani, Agarwal, Amit, Rifkin, Robert M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Haematological Malignancy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899784/
https://www.ncbi.nlm.nih.gov/pubmed/31382320
http://dx.doi.org/10.1111/bjh.16139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899784/
https://www.ncbi.nlm.nih.gov/pubmed/31382320
http://dx.doi.org/10.1111/bjh.16139

Ejemplares similares